The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Canine Stem Cell Therapy Market Research Report 2025
Synopsis
Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.
The global Canine Stem Cell Therapy market was valued at US$ 61 million in 2023 and is anticipated to reach US$ 79 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.
Market competition is intense. Medivet Biologics LLC, VETSTEM BIOPHARMA and J-ARM, etc. are the leaders of the industry, with about 52% market shares.
North America is the largest consumption region of animal stem cell therapy, with a consumption market share nearly 58%. Japan is the second largest supplier of animal stem cell therapy, enjoying production market share nearly 15%.
This report aims to provide a comprehensive presentation of the global market for Canine Stem Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Canine Stem Cell Therapy.
Report Scope
The Canine Stem Cell Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Canine Stem Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Canine Stem Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
VETSTEM BIOPHARMA
Cell Therapy Sciences
Regeneus
Aratana Therapeutics
Medivet Biologics
Okyanos
Vetbiologics
VetMatrix
Magellan Stem Cells
ANIMAL CELL THERAPIES
Stemcellvet
Segment by Type
Allogeneic Stem Cells
Autologous Stem cells
Segment by Application
Veterinary Hospitals
Veterinary Clinics
Veterinary Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Canine Stem Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.
The global Canine Stem Cell Therapy market was valued at US$ 61 million in 2023 and is anticipated to reach US$ 79 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.
Market competition is intense. Medivet Biologics LLC, VETSTEM BIOPHARMA and J-ARM, etc. are the leaders of the industry, with about 52% market shares.
North America is the largest consumption region of animal stem cell therapy, with a consumption market share nearly 58%. Japan is the second largest supplier of animal stem cell therapy, enjoying production market share nearly 15%.
This report aims to provide a comprehensive presentation of the global market for Canine Stem Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Canine Stem Cell Therapy.
Report Scope
The Canine Stem Cell Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Canine Stem Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Canine Stem Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
VETSTEM BIOPHARMA
Cell Therapy Sciences
Regeneus
Aratana Therapeutics
Medivet Biologics
Okyanos
Vetbiologics
VetMatrix
Magellan Stem Cells
ANIMAL CELL THERAPIES
Stemcellvet
Segment by Type
Allogeneic Stem Cells
Autologous Stem cells
Segment by Application
Veterinary Hospitals
Veterinary Clinics
Veterinary Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Canine Stem Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Canine Stem Cell Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Allogeneic Stem Cells
1.2.3 Autologous Stem cells
1.3 Market by Application
1.3.1 Global Canine Stem Cell Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Veterinary Hospitals
1.3.3 Veterinary Clinics
1.3.4 Veterinary Research Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Canine Stem Cell Therapy Market Perspective (2019-2030)
2.2 Canine Stem Cell Therapy Growth Trends by Region
2.2.1 Global Canine Stem Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Canine Stem Cell Therapy Historic Market Size by Region (2019-2024)
2.2.3 Canine Stem Cell Therapy Forecasted Market Size by Region (2025-2030)
2.3 Canine Stem Cell Therapy Market Dynamics
2.3.1 Canine Stem Cell Therapy Industry Trends
2.3.2 Canine Stem Cell Therapy Market Drivers
2.3.3 Canine Stem Cell Therapy Market Challenges
2.3.4 Canine Stem Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Canine Stem Cell Therapy Players by Revenue
3.1.1 Global Top Canine Stem Cell Therapy Players by Revenue (2019-2024)
3.1.2 Global Canine Stem Cell Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Canine Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Canine Stem Cell Therapy Revenue
3.4 Global Canine Stem Cell Therapy Market Concentration Ratio
3.4.1 Global Canine Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Canine Stem Cell Therapy Revenue in 2023
3.5 Canine Stem Cell Therapy Key Players Head office and Area Served
3.6 Key Players Canine Stem Cell Therapy Product Solution and Service
3.7 Date of Enter into Canine Stem Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Canine Stem Cell Therapy Breakdown Data by Type
4.1 Global Canine Stem Cell Therapy Historic Market Size by Type (2019-2024)
4.2 Global Canine Stem Cell Therapy Forecasted Market Size by Type (2025-2030)
5 Canine Stem Cell Therapy Breakdown Data by Application
5.1 Global Canine Stem Cell Therapy Historic Market Size by Application (2019-2024)
5.2 Global Canine Stem Cell Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Canine Stem Cell Therapy Market Size (2019-2030)
6.2 North America Canine Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Canine Stem Cell Therapy Market Size by Country (2019-2024)
6.4 North America Canine Stem Cell Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Canine Stem Cell Therapy Market Size (2019-2030)
7.2 Europe Canine Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Canine Stem Cell Therapy Market Size by Country (2019-2024)
7.4 Europe Canine Stem Cell Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Canine Stem Cell Therapy Market Size (2019-2030)
8.2 Asia-Pacific Canine Stem Cell Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Canine Stem Cell Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Canine Stem Cell Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Canine Stem Cell Therapy Market Size (2019-2030)
9.2 Latin America Canine Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Canine Stem Cell Therapy Market Size by Country (2019-2024)
9.4 Latin America Canine Stem Cell Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Canine Stem Cell Therapy Market Size (2019-2030)
10.2 Middle East & Africa Canine Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Canine Stem Cell Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Canine Stem Cell Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 VETSTEM BIOPHARMA
11.1.1 VETSTEM BIOPHARMA Company Detail
11.1.2 VETSTEM BIOPHARMA Business Overview
11.1.3 VETSTEM BIOPHARMA Canine Stem Cell Therapy Introduction
11.1.4 VETSTEM BIOPHARMA Revenue in Canine Stem Cell Therapy Business (2019-2024)
11.1.5 VETSTEM BIOPHARMA Recent Development
11.2 Cell Therapy Sciences
11.2.1 Cell Therapy Sciences Company Detail
11.2.2 Cell Therapy Sciences Business Overview
11.2.3 Cell Therapy Sciences Canine Stem Cell Therapy Introduction
11.2.4 Cell Therapy Sciences Revenue in Canine Stem Cell Therapy Business (2019-2024)
11.2.5 Cell Therapy Sciences Recent Development
11.3 Regeneus
11.3.1 Regeneus Company Detail
11.3.2 Regeneus Business Overview
11.3.3 Regeneus Canine Stem Cell Therapy Introduction
11.3.4 Regeneus Revenue in Canine Stem Cell Therapy Business (2019-2024)
11.3.5 Regeneus Recent Development
11.4 Aratana Therapeutics
11.4.1 Aratana Therapeutics Company Detail
11.4.2 Aratana Therapeutics Business Overview
11.4.3 Aratana Therapeutics Canine Stem Cell Therapy Introduction
11.4.4 Aratana Therapeutics Revenue in Canine Stem Cell Therapy Business (2019-2024)
11.4.5 Aratana Therapeutics Recent Development
11.5 Medivet Biologics
11.5.1 Medivet Biologics Company Detail
11.5.2 Medivet Biologics Business Overview
11.5.3 Medivet Biologics Canine Stem Cell Therapy Introduction
11.5.4 Medivet Biologics Revenue in Canine Stem Cell Therapy Business (2019-2024)
11.5.5 Medivet Biologics Recent Development
11.6 Okyanos
11.6.1 Okyanos Company Detail
11.6.2 Okyanos Business Overview
11.6.3 Okyanos Canine Stem Cell Therapy Introduction
11.6.4 Okyanos Revenue in Canine Stem Cell Therapy Business (2019-2024)
11.6.5 Okyanos Recent Development
11.7 Vetbiologics
11.7.1 Vetbiologics Company Detail
11.7.2 Vetbiologics Business Overview
11.7.3 Vetbiologics Canine Stem Cell Therapy Introduction
11.7.4 Vetbiologics Revenue in Canine Stem Cell Therapy Business (2019-2024)
11.7.5 Vetbiologics Recent Development
11.8 VetMatrix
11.8.1 VetMatrix Company Detail
11.8.2 VetMatrix Business Overview
11.8.3 VetMatrix Canine Stem Cell Therapy Introduction
11.8.4 VetMatrix Revenue in Canine Stem Cell Therapy Business (2019-2024)
11.8.5 VetMatrix Recent Development
11.9 Magellan Stem Cells
11.9.1 Magellan Stem Cells Company Detail
11.9.2 Magellan Stem Cells Business Overview
11.9.3 Magellan Stem Cells Canine Stem Cell Therapy Introduction
11.9.4 Magellan Stem Cells Revenue in Canine Stem Cell Therapy Business (2019-2024)
11.9.5 Magellan Stem Cells Recent Development
11.10 ANIMAL CELL THERAPIES
11.10.1 ANIMAL CELL THERAPIES Company Detail
11.10.2 ANIMAL CELL THERAPIES Business Overview
11.10.3 ANIMAL CELL THERAPIES Canine Stem Cell Therapy Introduction
11.10.4 ANIMAL CELL THERAPIES Revenue in Canine Stem Cell Therapy Business (2019-2024)
11.10.5 ANIMAL CELL THERAPIES Recent Development
11.11 Stemcellvet
11.11.1 Stemcellvet Company Detail
11.11.2 Stemcellvet Business Overview
11.11.3 Stemcellvet Canine Stem Cell Therapy Introduction
11.11.4 Stemcellvet Revenue in Canine Stem Cell Therapy Business (2019-2024)
11.11.5 Stemcellvet Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Canine Stem Cell Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Allogeneic Stem Cells
Table 3. Key Players of Autologous Stem cells
Table 4. Global Canine Stem Cell Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Canine Stem Cell Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Canine Stem Cell Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Canine Stem Cell Therapy Market Share by Region (2019-2024)
Table 8. Global Canine Stem Cell Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Canine Stem Cell Therapy Market Share by Region (2025-2030)
Table 10. Canine Stem Cell Therapy Market Trends
Table 11. Canine Stem Cell Therapy Market Drivers
Table 12. Canine Stem Cell Therapy Market Challenges
Table 13. Canine Stem Cell Therapy Market Restraints
Table 14. Global Canine Stem Cell Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Canine Stem Cell Therapy Market Share by Players (2019-2024)
Table 16. Global Top Canine Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Stem Cell Therapy as of 2023)
Table 17. Ranking of Global Top Canine Stem Cell Therapy Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Canine Stem Cell Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Canine Stem Cell Therapy Product Solution and Service
Table 21. Date of Enter into Canine Stem Cell Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Canine Stem Cell Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Canine Stem Cell Therapy Revenue Market Share by Type (2019-2024)
Table 25. Global Canine Stem Cell Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Canine Stem Cell Therapy Revenue Market Share by Type (2025-2030)
Table 27. Global Canine Stem Cell Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Canine Stem Cell Therapy Revenue Market Share by Application (2019-2024)
Table 29. Global Canine Stem Cell Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Canine Stem Cell Therapy Revenue Market Share by Application (2025-2030)
Table 31. North America Canine Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Canine Stem Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Canine Stem Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Canine Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Canine Stem Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Canine Stem Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Canine Stem Cell Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Canine Stem Cell Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Canine Stem Cell Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Canine Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Canine Stem Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Canine Stem Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Canine Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Canine Stem Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Canine Stem Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 46. VETSTEM BIOPHARMA Company Detail
Table 47. VETSTEM BIOPHARMA Business Overview
Table 48. VETSTEM BIOPHARMA Canine Stem Cell Therapy Product
Table 49. VETSTEM BIOPHARMA Revenue in Canine Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 50. VETSTEM BIOPHARMA Recent Development
Table 51. Cell Therapy Sciences Company Detail
Table 52. Cell Therapy Sciences Business Overview
Table 53. Cell Therapy Sciences Canine Stem Cell Therapy Product
Table 54. Cell Therapy Sciences Revenue in Canine Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 55. Cell Therapy Sciences Recent Development
Table 56. Regeneus Company Detail
Table 57. Regeneus Business Overview
Table 58. Regeneus Canine Stem Cell Therapy Product
Table 59. Regeneus Revenue in Canine Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 60. Regeneus Recent Development
Table 61. Aratana Therapeutics Company Detail
Table 62. Aratana Therapeutics Business Overview
Table 63. Aratana Therapeutics Canine Stem Cell Therapy Product
Table 64. Aratana Therapeutics Revenue in Canine Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 65. Aratana Therapeutics Recent Development
Table 66. Medivet Biologics Company Detail
Table 67. Medivet Biologics Business Overview
Table 68. Medivet Biologics Canine Stem Cell Therapy Product
Table 69. Medivet Biologics Revenue in Canine Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 70. Medivet Biologics Recent Development
Table 71. Okyanos Company Detail
Table 72. Okyanos Business Overview
Table 73. Okyanos Canine Stem Cell Therapy Product
Table 74. Okyanos Revenue in Canine Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 75. Okyanos Recent Development
Table 76. Vetbiologics Company Detail
Table 77. Vetbiologics Business Overview
Table 78. Vetbiologics Canine Stem Cell Therapy Product
Table 79. Vetbiologics Revenue in Canine Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 80. Vetbiologics Recent Development
Table 81. VetMatrix Company Detail
Table 82. VetMatrix Business Overview
Table 83. VetMatrix Canine Stem Cell Therapy Product
Table 84. VetMatrix Revenue in Canine Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 85. VetMatrix Recent Development
Table 86. Magellan Stem Cells Company Detail
Table 87. Magellan Stem Cells Business Overview
Table 88. Magellan Stem Cells Canine Stem Cell Therapy Product
Table 89. Magellan Stem Cells Revenue in Canine Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 90. Magellan Stem Cells Recent Development
Table 91. ANIMAL CELL THERAPIES Company Detail
Table 92. ANIMAL CELL THERAPIES Business Overview
Table 93. ANIMAL CELL THERAPIES Canine Stem Cell Therapy Product
Table 94. ANIMAL CELL THERAPIES Revenue in Canine Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 95. ANIMAL CELL THERAPIES Recent Development
Table 96. Stemcellvet Company Detail
Table 97. Stemcellvet Business Overview
Table 98. Stemcellvet Canine Stem Cell Therapy Product
Table 99. Stemcellvet Revenue in Canine Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 100. Stemcellvet Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Canine Stem Cell Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Canine Stem Cell Therapy Market Share by Type: 2023 VS 2030
Figure 3. Allogeneic Stem Cells Features
Figure 4. Autologous Stem cells Features
Figure 5. Global Canine Stem Cell Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Canine Stem Cell Therapy Market Share by Application: 2023 VS 2030
Figure 7. Veterinary Hospitals Case Studies
Figure 8. Veterinary Clinics Case Studies
Figure 9. Veterinary Research Institutes Case Studies
Figure 10. Canine Stem Cell Therapy Report Years Considered
Figure 11. Global Canine Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Canine Stem Cell Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Canine Stem Cell Therapy Market Share by Region: 2023 VS 2030
Figure 14. Global Canine Stem Cell Therapy Market Share by Players in 2023
Figure 15. Global Top Canine Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Stem Cell Therapy as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Canine Stem Cell Therapy Revenue in 2023
Figure 17. North America Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Canine Stem Cell Therapy Market Share by Country (2019-2030)
Figure 19. United States Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Canine Stem Cell Therapy Market Share by Country (2019-2030)
Figure 23. Germany Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Canine Stem Cell Therapy Market Share by Region (2019-2030)
Figure 31. China Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Canine Stem Cell Therapy Market Share by Country (2019-2030)
Figure 39. Mexico Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Canine Stem Cell Therapy Market Share by Country (2019-2030)
Figure 43. Turkey Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Canine Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. VETSTEM BIOPHARMA Revenue Growth Rate in Canine Stem Cell Therapy Business (2019-2024)
Figure 46. Cell Therapy Sciences Revenue Growth Rate in Canine Stem Cell Therapy Business (2019-2024)
Figure 47. Regeneus Revenue Growth Rate in Canine Stem Cell Therapy Business (2019-2024)
Figure 48. Aratana Therapeutics Revenue Growth Rate in Canine Stem Cell Therapy Business (2019-2024)
Figure 49. Medivet Biologics Revenue Growth Rate in Canine Stem Cell Therapy Business (2019-2024)
Figure 50. Okyanos Revenue Growth Rate in Canine Stem Cell Therapy Business (2019-2024)
Figure 51. Vetbiologics Revenue Growth Rate in Canine Stem Cell Therapy Business (2019-2024)
Figure 52. VetMatrix Revenue Growth Rate in Canine Stem Cell Therapy Business (2019-2024)
Figure 53. Magellan Stem Cells Revenue Growth Rate in Canine Stem Cell Therapy Business (2019-2024)
Figure 54. ANIMAL CELL THERAPIES Revenue Growth Rate in Canine Stem Cell Therapy Business (2019-2024)
Figure 55. Stemcellvet Revenue Growth Rate in Canine Stem Cell Therapy Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
